These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X. Warr TA; Rao LV; Rapaport SI Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494 [TBL] [Abstract][Full Text] [Related]
48. The effect of heparin removal in vitro on the activity of tissue factor pathway inhibitor. Mukherjee M Br J Haematol; 2000 Nov; 111(2):714-5. PubMed ID: 11189101 [No Abstract] [Full Text] [Related]
49. Therapeutic fibrinolysis. What should follow? Stead NW Circulation; 1991 Aug; 84(2):948-50. PubMed ID: 1860243 [No Abstract] [Full Text] [Related]
50. Expression of tissue factor and tissue factor pathway inhibitor in porcine endothelium in response to natural antibody and complement. Nagayasu T; Saadi S; Holzknecht RA; Miyata Y; Plummer TB; Platt JL Transplant Proc; 2001; 33(1-2):788. PubMed ID: 11267072 [No Abstract] [Full Text] [Related]
51. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Kondo S; Noguchi M; Funakoshi T; Fujikawa K; Kisiel W Thromb Res; 1987 Nov; 48(4):449-59. PubMed ID: 2965430 [TBL] [Abstract][Full Text] [Related]
52. Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group. Bara L; Leizorovicz A; Picolet H; Samama M Thromb Res; 1992 Mar; 65(4-5):641-50. PubMed ID: 1319619 [TBL] [Abstract][Full Text] [Related]
54. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Cardigan RA; McGloin H; Mackie IJ; Machin SJ; Singer M Kidney Int; 1999 Apr; 55(4):1568-74. PubMed ID: 10201024 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins. Hubbard AR; Jennings CA Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011 [TBL] [Abstract][Full Text] [Related]
57. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Sandset PM; Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI Proc Natl Acad Sci U S A; 1991 Feb; 88(3):708-12. PubMed ID: 1899482 [TBL] [Abstract][Full Text] [Related]
58. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells. Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992 [TBL] [Abstract][Full Text] [Related]
59. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]
60. Coagulation factor VII and malignant progression of hepatocellular carcinoma. Chen KD; Huang KT; Tsai MC; Wu CH; Kuo IY; Chen LY; Hu TH; Chen CL; Lin CC Cell Death Dis; 2016 Feb; 7(2):e2110. PubMed ID: 26913602 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]